The latest price target for Zimmer Biomet Holdings (NYSE:ZBH) was reported by RBC Capital on November 4, 2024. The analyst firm set a price target for $125.00 expecting ZBH to rise to within 12 months (a possible 14.76% upside). 50 analyst firms have reported ratings in the last year.

The latest analyst rating for Zimmer Biomet Holdings (NYSE:ZBH) was provided by RBC Capital, and Zimmer Biomet Holdings maintained their outperform rating.

The last upgrade for Zimmer Biomet Holdings Inc happened on May 21, 2024 when Argus Research raised their price target to $150. Argus Research previously had a hold for Zimmer Biomet Holdings Inc.

The last downgrade for Zimmer Biomet Holdings Inc happened on July 1, 2024 when Piper Sandler changed their price target from $140 to $115 for Zimmer Biomet Holdings Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zimmer Biomet Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zimmer Biomet Holdings was filed on November 4, 2024 so you should expect the next rating to be made available sometime around November 4, 2025.

While ratings are subjective and will change, the latest Zimmer Biomet Holdings (ZBH) rating was a maintained with a price target of $120.00 to $125.00. The current price Zimmer Biomet Holdings (ZBH) is trading at is $108.92, which is out of the analyst’s predicted range.